Does degree of androgen suppression matter in hormone-sensitive prostate cancer?
Prostate Cancer Research Program, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.
Daniel L
DL
Suzman
Prostate Cancer Research Program, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD eantona1@jhmi.edu.
Emmanuel S
ES
Antonarakis
D000726:Androgen Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D064129:Prostatic Neoplasms, Castration-Resistant / Q000188:drug therapy*; D013739:Testosterone / Q000097:blood*
D000726:Androgen Antagonists; D013739:Testosterone